| Product Code: ETC13208617 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Cannabis Medicine Market was valued at USD 13.8 Billion in 2024 and is expected to reach USD 27.5 Billion by 2031, growing at a compound annual growth rate of 9.20% during the forecast period (2025-2031).
The Global Cannabis Medicine Market is experiencing significant growth driven by increasing legalization of medical cannabis, growing acceptance of its therapeutic benefits, and a rising number of clinical trials exploring its potential applications. The market encompasses pharmaceuticals, wellness products, and medical devices derived from cannabis plants. North America dominates the market due to widespread legalization in countries like the United States and Canada, while Europe is also emerging as a key market with expanding regulatory approvals. Key players in the industry are focusing on research and development to create innovative cannabis-based products for various medical conditions such as chronic pain, epilepsy, cancer, and multiple sclerosis. The market is expected to continue its growth trajectory, propelled by increasing awareness and acceptance of cannabis as a viable medical treatment option worldwide.
The Global Cannabis Medicine Market is experiencing rapid growth due to increasing legalization and acceptance of medical cannabis worldwide. Key trends include the development of novel delivery methods such as oils, tinctures, and edibles, as well as the expansion of product offerings to include a wider range of cannabinoids beyond just THC and CBD. Opportunities within the market lie in the growing acceptance of cannabis as a treatment option for various medical conditions such as chronic pain, epilepsy, and anxiety, leading to increased research and investment in cannabis-based pharmaceuticals. Additionally, the market is seeing a rise in partnerships and collaborations between cannabis companies and traditional pharmaceutical companies, paving the way for new product development and increased market penetration.
The Global Cannabis Medicine Market faces several challenges, including regulatory hurdles and varying legal frameworks across different countries, which impact the production, distribution, and marketing of cannabis-based products. Additionally, the lack of standardization in dosing and formulations, as well as limited clinical research and evidence supporting the efficacy and safety of cannabis medicines, pose challenges for market growth. The stigma associated with cannabis use and the perception of marijuana as a recreational drug rather than a legitimate medical treatment further hinder market expansion. Moreover, competition from traditional pharmaceutical companies and the need for more education and awareness among healthcare professionals and consumers about the potential benefits of cannabis medicine present ongoing obstacles in the market.
The Global Cannabis Medicine Market is being primarily driven by increasing legalization of medical cannabis across various countries, growing acceptance of cannabis for therapeutic purposes, and rising awareness regarding the potential health benefits of cannabis-based products. Additionally, expanding research and development activities focused on exploring the medical applications of cannabis, coupled with the growing prevalence of chronic diseases such as cancer, epilepsy, and chronic pain, are further fueling the market growth. Moreover, the shift towards alternative treatment options and the emergence of innovative cannabis-derived pharmaceuticals are contributing to the expansion of the global cannabis medicine market. Overall, the increasing adoption of cannabis for medical purposes, along with favorable regulatory reforms, is expected to drive the market growth in the coming years.
Governments around the world have been implementing various policies related to the global cannabis medicine market. Countries like Canada and some states in the United States have legalized both medical and recreational cannabis, creating a growing market for cannabis-based medicines. Other countries have also begun to legalize medical cannabis, allowing for the production and distribution of pharmaceutical products derived from cannabis. However, regulations regarding the cultivation, production, and distribution of cannabis-based medicines vary widely across different regions, with some countries still maintaining strict restrictions. Additionally, research and clinical trials are being encouraged in many countries to further explore the potential medical benefits of cannabis and its derivatives, leading to a rapidly evolving landscape in the global cannabis medicine market.
The Global Cannabis Medicine Market is poised for significant growth in the coming years due to increasing legalization of medical cannabis across various countries and growing acceptance of cannabis for therapeutic purposes. Factors such as rising awareness about the potential health benefits of cannabis, expanding research and development activities in the field, and the increasing prevalence of chronic diseases are driving the market forward. Additionally, advancements in cultivation techniques, product innovation, and the emergence of new delivery methods are expected to further fuel market expansion. With the potential for more countries to legalize medical cannabis in the near future, the market is projected to experience substantial growth, offering opportunities for companies operating in the cannabis medicine sector to capitalize on the increasing demand for alternative treatment options.
In the global cannabis medicine market, North America is currently the dominant region due to the widespread legalization of medical cannabis in countries like the United States and Canada. The region boasts a well-established infrastructure for cannabis cultivation, research, and distribution. Europe is also emerging as a key market for cannabis medicine, with several countries legalizing medical cannabis and increasing acceptance among healthcare professionals. In Asia, there is a growing interest in cannabis medicine, particularly in countries like Israel and Australia, where research and development activities are gaining momentum. The Middle East and Africa are also showing potential for market growth, with several countries exploring the medicinal benefits of cannabis. Latin America, led by countries such as Colombia and Uruguay, is witnessing a rise in medical cannabis cultivation and export activities, positioning the region as a key player in the global market.
Global Cannabis Medicine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Cannabis Medicine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Cannabis Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Cannabis Medicine Market - Industry Life Cycle |
3.4 Global Cannabis Medicine Market - Porter's Five Forces |
3.5 Global Cannabis Medicine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Cannabis Medicine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Cannabis Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Cannabis Medicine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Cannabis Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Cannabis Medicine Market Trends |
6 Global Cannabis Medicine Market, 2021 - 2031 |
6.1 Global Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Cannabis Medicine Market, Revenues & Volume, By Prescription Drugs, 2021 - 2031 |
6.1.3 Global Cannabis Medicine Market, Revenues & Volume, By Recreational Drugs, 2021 - 2031 |
6.2 Global Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Cannabis Medicine Market, Revenues & Volume, By Chronic Pain, 2021 - 2031 |
6.2.3 Global Cannabis Medicine Market, Revenues & Volume, By Mental Disorders, 2021 - 2031 |
6.2.4 Global Cannabis Medicine Market, Revenues & Volume, By Cancer, 2021 - 2031 |
6.3 Global Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Cannabis Medicine Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.3.3 Global Cannabis Medicine Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.3.4 Global Cannabis Medicine Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Cannabis Medicine Market, Overview & Analysis |
7.1 North America Cannabis Medicine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Cannabis Medicine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Cannabis Medicine Market, Overview & Analysis |
8.1 Latin America (LATAM) Cannabis Medicine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Cannabis Medicine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Cannabis Medicine Market, Overview & Analysis |
9.1 Asia Cannabis Medicine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Cannabis Medicine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Cannabis Medicine Market, Overview & Analysis |
10.1 Africa Cannabis Medicine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Cannabis Medicine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Cannabis Medicine Market, Overview & Analysis |
11.1 Europe Cannabis Medicine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Cannabis Medicine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Cannabis Medicine Market, Overview & Analysis |
12.1 Middle East Cannabis Medicine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Cannabis Medicine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Cannabis Medicine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Cannabis Medicine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Cannabis Medicine Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Cannabis Medicine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Cannabis Medicine Market Key Performance Indicators |
14 Global Cannabis Medicine Market - Export/Import By Countries Assessment |
15 Global Cannabis Medicine Market - Opportunity Assessment |
15.1 Global Cannabis Medicine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Cannabis Medicine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Cannabis Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Cannabis Medicine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Cannabis Medicine Market - Competitive Landscape |
16.1 Global Cannabis Medicine Market Revenue Share, By Companies, 2024 |
16.2 Global Cannabis Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |